[Application of paramunity inducers in small animal practice]

Area of Science:

• Veterinary immunology
• Virology
• Animal infectious diseases

Background:

• Paramunity inducers, derived from attenuated poxviruses (avipox and parapox viruses), have a long history of use in small animals.
• Applications span both therapeutic and prophylactic strategies across various animal diseases.
• Published placebo-controlled studies remain scarce despite widespread application.

Purpose of the Study:

• To evaluate the efficacy of paramunity inducers in treating specific animal infectious diseases.
• To assess the therapeutic and prophylactic benefits of these viral-based treatments.
• To consolidate evidence from controlled studies on paramunity inducer effectiveness.

Main Methods:

• Review of existing literature focusing on placebo-controlled studies of paramunity inducers.
• Analysis of reported outcomes in therapeutic and prophylactic applications.
• Statistical evaluation of efficacy in conditions like feline stomatitis, kitten mortality, canine parvovirus, feline leukemia virus, and canine papillomavirus infections.

Main Results:

• Positive effects reported for preventing kitten mortality and treating feline stomatitis.
• No statistically significant therapeutic effects demonstrated for canine parvovirus infection.
• Lack of demonstrated efficacy for feline leukemia virus infection and canine papillomavirus infection.

Conclusions:

• Paramunity inducers demonstrate variable efficacy, with positive outcomes in specific prophylactic and therapeutic scenarios.
• Current evidence does not support the therapeutic use of paramunity inducers for key infectious diseases like canine parvovirus and feline leukemia virus.
• Further rigorous, placebo-controlled research is needed to clarify the role of paramunity inducers in veterinary medicine.